🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Drug Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Sellers market the substance there before redirecting buyers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could result in individuals administering products of unknown origin.

Several experts said the demand for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach pharmaceutical, advertising, and customer regulations, potentially leading to fines, legal action or imprisonment.

Platform Response and Content Removal

Based on the social media company, the service has taken down problematic material and prohibited associated keywords and query recommendations. The company stated it was dedicated to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 members selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of members, populated with images of slimming results, glowing testimonials and detailed instructions for mixing or administering at home.

Within minutes of entering one community, a seller shared WhatsApp details, where most transactions take place. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about body mass, medical conditions or past usage.

Product Details and Costs

Within these groups, posts display dark colored parcels with postal service stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When asked how long a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram said it actively moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering substances they cannot confirm. Even if the science behind this drug is sound, these online versions may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.

Her staff has already seen individuals injured by personal administration from unverified sources. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to possibly significant health risks”.